Long-Term Iron Chelation Therapy with Deferiprone in Patients with Thalassemia Major and Low Iron Load

被引：1
|
作者：
Daar, Shahina [1 ]
Al-Khabori, Murtadha K. [2 ]
Al Farsi, Khalil [3 ]
Al-Rawahi, Bader Abdulla [1 ]
Al-Riyami, Arwa Z. [1 ,4 ]
机构：
[1] Sultan Qaboos Univ Hosp, Muscat, Oman
[2] Sultan Qaboos Univ Hosp, Dept Haematol, Muscat, Oman
[3] Sultan Qaboos Univ Hosp, Dept Haematol, Coll Med & Hlth Sci, Muscat, Oman
[4] Sultan Qaboos Univ Hosp, Al Khoud, Oman
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3626.3626
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3626
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major
    Olivieri, NF
    Brittenham, GM
    McLaren, CE
    Templeton, DM
    Cameron, RG
    McClelland, RA
    Burt, AD
    Fleming, KA
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (07): : 417 - 423
  • [2] Hepatic and Cardiac Iron-load in Children on Long-term Chelation with Deferiprone for Thalassemia Major
    Totadri, Sidharth
    Bansal, Deepak
    Trehan, Amita
    Khadwal, Alka
    Bhatia, Anmol
    Sodhi, Kushaljit Singh
    Bhatia, Prateek
    Jain, Richa
    Das, Reena
    Khandelwal, Niranjan
    INDIAN PEDIATRICS, 2018, 55 (07) : 573 - 575
  • [3] Hepatic and Cardiac Iron-load in Children on Long-term Chelation with Deferiprone for Thalassemia Major
    Sidharth Totadri
    Deepak Bansal
    Amita Trehan
    Alka Khadwal
    Anmol Bhatia
    Kushaljit Singh Sodhi
    Prateek Bhatia
    Richa Jain
    Reena Das
    Niranjan Khandelwal
    Indian Pediatrics, 2018, 55 : 573 - 575
  • [4] IRON-CHELATION THERAPY WITH ORAL DEFERIPRONE IN PATIENTS WITH THALASSEMIA MAJOR
    OLIVIERI, NF
    BRITTENHAM, GM
    MATSUI, D
    BERKOVITCH, M
    BLENDIS, LM
    CAMERON, RG
    MCCLELLAND, RA
    LIU, PP
    TEMPLETON, DM
    KOREN, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14): : 918 - 922
  • [5] Iron chelation with oral deferiprone in patients with thalassemia
    Nathan, DG
    Weatherall, DJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23): : 1711 - 1712
  • [6] Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in β-thalassemia
    Tsironi, Maria
    Assimakopoulos, George
    Polonofi, Katerina
    Rigaki, Kalliopi
    Aessopos, Athanassios
    HEMOGLOBIN, 2008, 32 (1-2) : 29 - 34
  • [7] Long-term effects of combined chelation therapy in thalassemia major patients with iron-induced cardiomyopathy
    Pepe, A.
    Grady, R.
    Vacquer, S.
    Carta, P.
    Sau, F.
    Bina, P.
    Cianciulli, P.
    Maggio, A.
    Lombardi, M.
    Lai, M. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 51 - 51
  • [8] Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients
    Wu, Shu-Fen
    Peng, Ching-Tien
    Wu, Kang-Hsi
    Tsai, Chang-Hai
    HEMOGLOBIN, 2006, 30 (02) : 215 - 218
  • [9] Iron chelation therapy in thalassemia major
    Guven, sirin
    Erdogan, Makbule
    MEDICAL JOURNAL OF BAKIRKOY, 2007, 3 (04) : 125 - 129
  • [10] Deferiprone Chelation Therapy for Thalassemia Major
    Galanello, R.
    Campus, S.
    ACTA HAEMATOLOGICA, 2009, 122 (2-3) : 155 - 164
12345